1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Osteoporosis

Osteoporosis: assessing the risk of fragility fracture

Clinical guideline [CG146] Published: 08 August 2012 Last updated: 07 February 2017

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
  • About this information
  • Your care
  • Osteoporosis-related fractures
  • Who should be assessed for fracture risk?
  • How should fracture risk be assessed?
  • More information
  • Other NICE guidance
Download (PDF)

Information for the public

Other NICE guidance

Other NICE guidance

NICE has also produced the following guidance:

  • Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

  • Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women

  • Falls in older people: assessing risk and prevention

  • Hip fracture: management

ISBN: 978-1-4731-3517-8

  • Information Standard